BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12234934)

  • 21. Requirements for interleukin-4-induced gene expression and functional characterization of Stat6.
    Mikita T; Campbell D; Wu P; Williamson K; Schindler U
    Mol Cell Biol; 1996 Oct; 16(10):5811-20. PubMed ID: 8816495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An LXXLL motif in the transactivation domain of STAT6 mediates recruitment of NCoA-1/SRC-1.
    Litterst CM; Pfitzner E
    J Biol Chem; 2002 Sep; 277(39):36052-60. PubMed ID: 12138096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM; Woisetschläger M
    J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic analysis of STAT6 signalling in living cells.
    Nelson G; Wilde GJ; Spiller DG; Sullivan E; Unitt JF; White MR
    FEBS Lett; 2002 Dec; 532(1-2):188-92. PubMed ID: 12459487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression.
    Dickensheets HL; Venkataraman C; Schindler U; Donnelly RP
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10800-5. PubMed ID: 10485906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional activation by STAT6 requires the direct interaction with NCoA-1.
    Litterst CM; Pfitzner E
    J Biol Chem; 2001 Dec; 276(49):45713-21. PubMed ID: 11574547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-4/STAT6 represses STAT1 and NF-kappa B-dependent transcription through distinct mechanisms.
    Ohmori Y; Hamilton TA
    J Biol Chem; 2000 Dec; 275(48):38095-103. PubMed ID: 10982806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic activation of the germline epsilon promoter mediated by Stat6 and C/EBP beta.
    Mikita T; Kurama M; Schindler U
    J Immunol; 1998 Aug; 161(4):1822-8. PubMed ID: 9712049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a STAT6 domain required for IL-4-induced activation of transcription.
    Lu B; Reichel M; Fisher DA; Smith JF; Rothman P
    J Immunol; 1997 Aug; 159(3):1255-64. PubMed ID: 9233621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-gamma activation site-like sequence upstream of the I epsilon exon in a human B cell line. Evidence for the involvement of Janus kinase 3 and interleukin-4 Stat.
    Fenghao X; Saxon A; Nguyen A; Ke Z; Diaz-Sanchez D; Nel A
    J Clin Invest; 1995 Aug; 96(2):907-14. PubMed ID: 7635985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene.
    Kotanides H; Reich NC
    J Biol Chem; 1996 Oct; 271(41):25555-61. PubMed ID: 8810328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation.
    Goenka S; Youn J; Dzurek LM; Schindler U; Yu-Lee LY; Boothby M
    J Immunol; 1999 Nov; 163(9):4663-72. PubMed ID: 10528163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of p100 target promoters by chromatin immunoprecipitation-guided ligation and selection (ChIP-GLAS).
    Liu X; Dong L; Zhang X; Wang B; Wang X; Li H; He J; Ge L; Jing X; Yao Z; Yang J
    Cell Mol Immunol; 2011 Jan; 8(1):88-91. PubMed ID: 20921938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6.
    Patel BK; Pierce JH; LaRochelle WJ
    Proc Natl Acad Sci U S A; 1998 Jan; 95(1):172-7. PubMed ID: 9419348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Essential role of Stat6 in IL-4 signalling.
    Takeda K; Tanaka T; Shi W; Matsumoto M; Minami M; Kashiwamura S; Nakanishi K; Yoshida N; Kishimoto T; Akira S
    Nature; 1996 Apr; 380(6575):627-30. PubMed ID: 8602263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stat6 inhibits human interleukin-4 promoter activity in T cells.
    Georas SN; Cumberland JE; Burke TF; Chen R; Schindler U; Casolaro V
    Blood; 1998 Dec; 92(12):4529-38. PubMed ID: 9845517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperation of the transcriptional coactivators CBP and p300 with Stat6.
    McDonald C; Reich NC
    J Interferon Cytokine Res; 1999 Jul; 19(7):711-22. PubMed ID: 10454341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism.
    Suzuki K; Nakajima H; Kagami S; Suto A; Ikeda K; Hirose K; Hiwasa T; Takeda K; Saito Y; Akira S; Iwamoto I
    J Exp Med; 2002 Jul; 196(1):27-38. PubMed ID: 12093868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTB-associated splicing factor (PSF) functions as a repressor of STAT6-mediated Ig epsilon gene transcription by recruitment of HDAC1.
    Dong L; Zhang X; Fu X; Zhang X; Gao X; Zhu M; Wang X; Yang Z; Jensen ON; Saarikettu J; Yao Z; Silvennoinen O; Yang J
    J Biol Chem; 2011 Feb; 286(5):3451-9. PubMed ID: 21106524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
    Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
    J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.